Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Excler

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
NPJ Vaccines|August 25, 2023
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation effortsJung-Seok Lee, Vittal Mogasale, Sol Kim, et al.
Vaccine|July 20, 2025
Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerationsJean-Louis Excler, Tarun Saluja, Annelies Wilder-Smith, et al.
BMJ Global Health|June 8, 2023
Vaccine access, equity and justice: COVID-19 vaccines and vaccinationLois Privor-Dumm, Jean-Louis Excler, Sarah Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018Samuel Kim, Kang Sung Lee, Gi Deok Pak, et al.
Vaccine|June 17, 2022
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virusLibia Milena Hernandez, K Sumathy, Sushant Sahastrabuddhe, et al.
The Indian Journal of Medical Research|September 4, 2008
Preparedness for AIDS vaccine trials in IndiaJean-Louis Excler, Sonali Kochhar, Sushma Kapoor, et al.
BMJ Global Health|June 5, 2023
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threatsPeter J Hotez, Sarah Gilbert, Melanie Saville, et al.
BMJ Global Health|June 5, 2023
Factors, enablers and challenges for COVID-19 vaccine developmentJean-Louis Excler, Melanie Saville, Lois Privor-Dumm, et al.
NPJ Vaccines|August 9, 2023
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritizationDonald R Walkinshaw, Meghan E E Wright, Marni Williams, et al.
AIDS Research and Human Retroviruses|June 25, 2015
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention TrialsNittaya Phanuphak, Ying-Ru Lo, Yiming Shao, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
NPJ Vaccines|August 25, 2023
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation effortsJung-Seok Lee, Vittal Mogasale, Sol Kim, et al.
Vaccine|July 20, 2025
Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerationsJean-Louis Excler, Tarun Saluja, Annelies Wilder-Smith, et al.
BMJ Global Health|June 8, 2023
Vaccine access, equity and justice: COVID-19 vaccines and vaccinationLois Privor-Dumm, Jean-Louis Excler, Sarah Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018Samuel Kim, Kang Sung Lee, Gi Deok Pak, et al.
Vaccine|June 17, 2022
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virusLibia Milena Hernandez, K Sumathy, Sushant Sahastrabuddhe, et al.
The Indian Journal of Medical Research|September 4, 2008
Preparedness for AIDS vaccine trials in IndiaJean-Louis Excler, Sonali Kochhar, Sushma Kapoor, et al.
BMJ Global Health|June 5, 2023
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threatsPeter J Hotez, Sarah Gilbert, Melanie Saville, et al.
BMJ Global Health|June 5, 2023
Factors, enablers and challenges for COVID-19 vaccine developmentJean-Louis Excler, Melanie Saville, Lois Privor-Dumm, et al.
NPJ Vaccines|August 9, 2023
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritizationDonald R Walkinshaw, Meghan E E Wright, Marni Williams, et al.
AIDS Research and Human Retroviruses|June 25, 2015
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention TrialsNittaya Phanuphak, Ying-Ru Lo, Yiming Shao, et al.
Pageof 12